Jan Saevels

423 total citations
28 papers, 265 citations indexed

About

Jan Saevels is a scholar working on Biomedical Engineering, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Jan Saevels has authored 28 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomedical Engineering, 6 papers in Geriatrics and Gerontology and 5 papers in Molecular Biology. Recurrent topics in Jan Saevels's work include Microfluidic and Capillary Electrophoresis Applications (10 papers), Innovative Microfluidic and Catalytic Techniques Innovation (6 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Jan Saevels is often cited by papers focused on Microfluidic and Capillary Electrophoresis Applications (10 papers), Innovative Microfluidic and Catalytic Techniques Innovation (6 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Jan Saevels collaborates with scholars based in Belgium, Italy and Netherlands. Jan Saevels's co-authors include Ann Van Schepdael, Jos Hoogmartens, Yvan Vander Heyden, Debby Mangelings, Jos Hoogmartens, Valérie Vanhoorne, Hartmut Derendorf, Martina Teichert, Ross T. Tsuyuki and Hans De Loof and has published in prestigious journals such as Analytical Chemistry, The Science of The Total Environment and Analytical Biochemistry.

In The Last Decade

Jan Saevels

26 papers receiving 260 citations

Peers

Countries citing papers authored by Jan Saevels

Since Specialization

Citations

This map shows the geographic impact of Jan Saevels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Saevels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Saevels more than expected).

Fields of papers citing papers by Jan Saevels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Saevels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Saevels. The network helps show where Jan Saevels may publish in the future.

Co-authorship network of co-authors of Jan Saevels

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Saevels. A scholar is included among the top collaborators of Jan Saevels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Saevels. Jan Saevels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Do the lockdown-imposed changes in a wastewater treatment plant catchment's socio-demographics impact longitudinal temporal trends in psychoactive pharmaceutical use? 2023 ·The Science of The Total Environment ·Tim Boogaerts, (unknown), Hans De Loof, (unknown), (unknown), (unknown), Jan Saevels, Lies Lahousse, (unknown), (unknown), Bert Aertgeerts, Adrian Covaci, Alexander L.N. van Nuijs	9
2	Quality Care Program: Raise awareness, motivate and coach community-pharmacists to provide high-quality pharmaceutical care. 2023 ·International Journal of Integrated Care ·Jan Saevels, (unknown), (unknown), (unknown)	0
3	Out of pocket expenses: effect of fee-waivers on opioid prescribing and dispensing 2021 ·International Journal of Drug Policy ·Tim Boogaerts, (unknown), Adrian Covaci, Alexander L.N. van Nuijs, (unknown), Jan Saevels, Hans De Loof	2
4	Development of a 3D-Printed Dosing Platform to Aid in Zolpidem Withdrawal Therapy 2021 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), (unknown), Jan Saevels, Valérie Vanhoorne, Chris Vervaet	18
5	Belgian community pharmacists’ pharmacovigilance perspective and practice 2019 ·Research in Social and Administrative Pharmacy ·(unknown), Jan Saevels	4
6	Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia-Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implemen 2018 ·International Journal of Clinical Pharmacology and Therapeutics ·Olaf Rose, Hartmut Derendorf, (unknown), (unknown), (unknown), Kreshnik Hoti, Ines Krass, (unknown), Jan Saevels, (unknown), Martina Teichert, Ross T. Tsuyuki	21
7	Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium 2016 ·Research in Social and Administrative Pharmacy ·Jessica Fraeyman, Veerle Foulon, Els Mehuys, Koen Boussery, Jan Saevels, Carine De Vriese, Olivia Dalleur, (unknown), Stéphane Steurbaut, (unknown), Guido R.Y. De Meyer, Hans De Loof, Guido Van Hal, Stephan Van den Broucke	16
8	[Influenza vaccination in community pharmacies 2009/2010]. 2010 ·PubMed ·(unknown), Jan Saevels	3
9	Precision study on capillary electrophoresis methods for metacycline 2006 ·Electrophoresis ·Thao Do Thi, Romeo Pomponio, Roberto Gotti, Jan Saevels, (unknown), (unknown), Nele Matthijs, Yvan Vander Heyden, (unknown), Patrice Chiap, Philippe Hubert, Jacques Crommen, H. Fabre, Pieter Dehouck, Jos Hoogmartens, Ann Van Schepdael	8
10	Enantiomeric impurity determination of levetiracetam using capillary electrochromatography 2006 ·Journal of Separation Science ·Debby Mangelings, Jan Saevels, Yvan Vander Heyden	14
11	Integration of Phosphodiesterase-Induced Degradation of Oligonucleotides with Capillary Polymer-Sieving Electrophoresis 2003 ·Humana Press eBooks ·Jan Saevels, Ann Van Schepdael, Jos Hoogmartens	1
12	Capillary Electrophoresis of RNA Oligonucleotides: Catalytic Activity of a Hammerhead Ribozyme 1999 ·Analytical Biochemistry ·Jan Saevels, Ann Van Schepdael, Jos Hoogmartens	16
13	Interlaboratory study comparing the microbiological potency of spiramycins I, II and III 1999 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Jan Saevels, Pierre Louis, Hans J. Nelis, (unknown), Katelijne Dierick, (unknown), E. Roets, Jos Hoogmartens	5
14	In-house packing and testing of capillaries for capillary electrochromatography using simple equipment 1999 ·Journal of Pharmaceutical and Biomedical Analysis ·Jan Saevels, (unknown), Ann Van Schepdael, (unknown), Jos Hoogmartens	13
15	Interlaboratory studies on two high-performance liquid chromatographic assays for tylosin (tartrate) 1999 ·Journal of Chromatography A ·Yvan Vander Heyden, Jan Saevels, E. Roets, Jos Hoogmartens, (unknown), M.G. Quaglia, W. Van den Bossche, (unknown), (unknown), (unknown), Bruce D. Mason, (unknown), W.J.M. Underberg, A. Bult, Patrice Chiap, Jacques Crommen, J. De Beer, (unknown), D.L. Massart	17
16	Separation of tetracycline and its related substances: comparison of liquid chromatography, capillary electrophoresis and capillary electrochromatography 1998 ·Biomedical Chromatography ·Jan Saevels, (unknown), Ann Van Schepdael, E. Roets, Jos Hoogmartens	4
17	Investigation of unexpected migration behavior of adenosine in capillary zone electrophoresis 1998 ·Chromatographia ·Jan Saevels, (unknown), (unknown), Ann Van Schepdael, Jos Hoogmartens	3
18	Phosphodiesterase susceptibility of modified oligonucleotides studied in an integrated capillary electrophoresis system. 1998 ·PubMed ·Jan Saevels, Ann Van Schepdael, Jos Hoogmartens	3
19	Determination of the kinetic parameters of adenosine deaminase by electrophoretically mediated microanalysis 1996 ·Electrophoresis ·Jan Saevels, Ann Van Schepdael, Jos Hoogmartens	40
20	Separation of tetracycline and its related substances by capillary zone electrophoresis 1995 ·Journal of High Resolution Chromatography ·Ann Van Schepdael, Jan Saevels, (unknown), (unknown), (unknown), (unknown), Jos Hoogmartens	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact